MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Impact of istradefylline on the onset of dyskinesia in Parkinson’s Disease patients with wearing off: a randomized controlled study (ODYSSEI)

    Y. Tsuboi, T. Hasegawa, Y. Shimo, S. Kaneko, M. Tomiyama, K. Kashihara, S. Chiu, T. Yamaguchi (Fukuoka, Japan)

    Objective: To determine the effect of long-term treatment with istradefylline (IST) on the time to onset of dyskinesia in Parkinson’s disease (PD) patients with wearing-off…
  • 2023 International Congress

    Holmes Tremor and Dystonia as Manifestation of Benedikt Syndrome in HIV-Related Cerebral Toxoplasmosis : A Case Report

    NER. Raisa, AC. Pratiwi, SB. Rianawati, BDM. Munir (Malang, Indonesia)

    Objective: To present movement disorder symptoms of Holmes tremor and dystonia as part of Benedikt Syndrome in a patient diagnosed with HIV-Related Cerebral Toxoplasmosis Background:…
  • 2023 International Congress

    Is there a common structural network for stimulation-induced dysarthria in subthalamic and thalamic deep brain stimulation?

    JN. Petry-Schmelzer, H. Jergas, T. Thies, JC. Baldermann, V. Visser-Vandewalle, TA. Dembek, MT. Barbe (Cologne, Germany)

    Objective: To identify a common structural network for stimulation-induced dysarthria (SID) in thalamic deep brain stimulation (DBS) and DBS of the Nucleus subthalamicus (STN). Background:…
  • 2023 International Congress

    Characterisation of OFF-Time in Levodopa-Treated Parkinson’s Patients: A Post-hoc Analysis of an Exploratory Trial

    J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, B. Guimarães, J-F. Rocha (Lisbon, Portugal)

    Objective: This analysis aims to study the evolution of OFF and ON patterns during a 12-hour daily period in patients with Parkinson’s disease (PD) and…
  • 2023 International Congress

    Brain metabolic response of primary sensory cortex transcranial magnetic stimulation in cervical dystonia

    A. Kokkonen, DT. Corp, J. Joutsa (Turku, Finland)

    Objective: To investigate the effects of continuous theta burst stimulation (cTBS) in cervical dystonia targeted to the brain network identified based on causal brain lesions.…
  • 2023 International Congress

    Experiences of People with Parkinson’s Disease use of a wearable technology for the management of drooling; qualitative insights from the Cue Band study

    L. Dismore, K. Montague, T. Guerreiro, L. Carvalho, D. Jackson, R. Walker (Newcastle upon Tyne, United Kingdom)

    Objective: In the Cue Band study, people with Parkinson’s Disease (PwP) are participating in a randomised controlled trial to compare a mobile Application (App) with…
  • 2023 International Congress

    Inferring Rigidity Scores in MDS-UPDRS Motor Assessment from Other Items

    F. Duque Quiceno, Y. Dushin, G. Sarapata, S. Komarov, A. Matveev, J. O'Keeffe (London, United Kingdom)

    Objective: This study aimed to explore the possibility of inferring rigidity scores in MDS-UPDRS assessments from other items to enhance the accuracy of clinical evaluations…
  • 2023 International Congress

    Apathy and impulsivity co-occur in Huntington’s disease

    L. Morris, K. Horne, L. Paermentier, C. Buchanan, M. Macaskill, D. Myall, M. Husain, R. Roxburgh, T. Anderson, C. Le Heron (Christchurch, New Zealand)

    Objective: To determine whether apathy and impulsivity co-occur in people with Huntington’s disease. Background: Apathy and impulsivity are debilitating behavioural changes which often occur in…
  • 2023 International Congress

    Clinical spectrum, imaging characteristics and care giver burden assessment of early onset non-dominant progressive cerebellar ataxias

    R. Devaraj, P. Pal, N. M, RY. Yadav, M. Faruq, J. Saini, S. Hegde (Bangalore, India)

    Objective: To characterise the phenotypic and radiological spectrum of patients with early onset non-dominant progressive cerebellar ataxias and to assess the impact of the disease…
  • 2023 International Congress

    Describing the syndrome: a comprehensive analysis of a large cohort of corticobasal syndrome with pathological correlation

    D. Vaughan, M. Theilmann Jensen, D. Lux, L. Wu, Z. Jaunmuktane, T. Revesz, T. Lynch, M. Stamelou, K. Seppi, R. Vandenberghe, T. Warner, K. Bhatia, A. Lees, A. Church, N. Leigh, P. Taba, T. Matsalu, P. Mir, B. Ghosh, M. Picillo, J. Wallin, P. Svenningsson, Y. Compta, J. Rohrer, J. Rowe, H. Morris (London, United Kingdom)

    Objective: To describe the clinical, biomarker, genetic and pathological features of a cohort of patients with corticobasal syndrome (CBS). Background: Corticobasal degeneration (CBD) was first…
  • « Previous Page
  • 1
  • …
  • 219
  • 220
  • 221
  • 222
  • 223
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley